Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Therapeutic Innovation & Regulatory Science
|
July 1, 2021
elaborator: A Novel App for Insights into Laboratory Data of Clinical Trials
Silke Janitza, Madhurima Majumder, Franco Mendolia, et al.
Digital Biomarkers
|
March 19, 2025
Interpretation of Change in Novel Digital Measures: A Statistical Review and Tutorial
Andrew Trigg, Bohdana Ratitch, Frank Kruesmann, et al.
Digital Biomarkers
|
August 17, 2023
Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation
Bohdana Ratitch, Andrew Trigg, Madhurima Majumder, et al.
Orphanet Journal of Rare Diseases
|
May 7, 2022
Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles
Kelley M Kidwell, Satrajit Roychoudhury, Barbara Wendelberger, et al.
Journal of Huntington'S Disease
|
July 4, 2017
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials
Haruhiko Banno, Kelly L Andrzejewski, Michael P McDermott, et al.
Blood Advances
|
August 25, 2022
Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr
Joseph S Palumbo, Anthonie W A Lensing, Leonardo R Brandão, et al.
Blood Advances
|
October 1, 2020
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)
Katharina Thom, Anthonie W A Lensing, Ildar Nurmeev, et al.
Blood Advances
|
December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)
Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
The Lancet. Haematology
|
November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
Christoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Therapeutic Innovation & Regulatory Science
|
July 1, 2021
elaborator: A Novel App for Insights into Laboratory Data of Clinical Trials
Silke Janitza, Madhurima Majumder, Franco Mendolia, et al.
Digital Biomarkers
|
March 19, 2025
Interpretation of Change in Novel Digital Measures: A Statistical Review and Tutorial
Andrew Trigg, Bohdana Ratitch, Frank Kruesmann, et al.
Digital Biomarkers
|
August 17, 2023
Clinical Validation of Novel Digital Measures: Statistical Methods for Reliability Evaluation
Bohdana Ratitch, Andrew Trigg, Madhurima Majumder, et al.
Orphanet Journal of Rare Diseases
|
May 7, 2022
Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles
Kelley M Kidwell, Satrajit Roychoudhury, Barbara Wendelberger, et al.
Journal of Huntington'S Disease
|
July 4, 2017
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials
Haruhiko Banno, Kelly L Andrzejewski, Michael P McDermott, et al.
Blood Advances
|
August 25, 2022
Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr
Joseph S Palumbo, Anthonie W A Lensing, Leonardo R Brandão, et al.
Blood Advances
|
October 1, 2020
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)
Katharina Thom, Anthonie W A Lensing, Ildar Nurmeev, et al.
Blood Advances
|
December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)
Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
The Lancet. Haematology
|
November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
Christoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
Page
of 1